Published in Br J Pharmacol on August 01, 2001
The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential. Pharmacol Rev (2015) 1.38
Two components of voltage-dependent inactivation in Ca(v)1.2 channels revealed by its gating currents. Biophys J (2003) 0.89
Negatively charged residues in the N-terminal of the AID helix confer slow voltage dependent inactivation gating to CaV1.2. Biophys J (2004) 0.89
Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets? Curr Mol Pharmacol (2015) 0.81
Calcium entry leads to inactivation of calcium channel in Paramecium. Science (1978) 5.75
Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state. Proc Natl Acad Sci U S A (1984) 5.33
Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel. Nature (1989) 5.21
Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists. Circ Res (1984) 3.47
Ca2+/calmodulin binds to and modulates P/Q-type calcium channels. Nature (1999) 3.24
Nomenclature of voltage-gated calcium channels. Neuron (2000) 3.09
Subunit interaction sites in voltage-dependent Ca2+ channels: role in channel function. Trends Neurosci (1998) 2.24
Structural basis of drug binding to L Ca2+ channels. Trends Pharmacol Sci (1998) 1.69
Assay for calcium channels. Methods Enzymol (1985) 1.60
Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels. Neuron (1996) 1.46
Ionic channels in excitable membranes. Current problems and biophysical approaches. Biophys J (1978) 1.45
Endogenous calcium channels in human embryonic kidney (HEK293) cells. Br J Pharmacol (1996) 1.31
Molecular determinants of inactivation in voltage-gated Ca2+ channels. J Physiol (2000) 1.30
Ca2+ channel block and inactivation: common molecular determinants. Trends Pharmacol Sci (1998) 1.14
Analysis of the dihydropyridine receptor site of L-type calcium channels by alanine-scanning mutagenesis. J Biol Chem (1997) 1.07
Molecular localization of regions in the L-type calcium channel critical for dihydropyridine action. Neuron (1993) 1.04
Nine L-type amino acid residues confer full 1,4-dihydropyridine sensitivity to the neuronal calcium channel alpha1A subunit. Role of L-type Met1188. J Biol Chem (1997) 1.02
Molecular determinants of high affinity dihydropyridine binding in L-type calcium channels. J Biol Chem (1996) 0.98
Molecular properties of a superfamily of plasma-membrane cation channels. Curr Opin Cell Biol (1994) 0.95
Molecular mechanism of calcium channel block by isradipine. Role of a drug-induced inactivated channel conformation. J Biol Chem (2000) 0.92
Transfer of the high affinity dihydropyridine sensitivity from L-type To non-L-type calcium channel. Mol Pharmacol (1997) 0.90
Sequence differences between alpha1C and alpha1S Ca2+ channel subunits reveal structural determinants of a guarded and modulated benzothiazepine receptor. J Biol Chem (1999) 0.90
Isradipine interacts with the open state of the L-type calcium channel at high concentrations. Receptors Channels (1998) 0.87
Dihydropyridine enantiomers block recombinant L-type Ca2+ channels by two different mechanisms. J Physiol (1999) 0.87
Cardiac effects of isradipine in patients with hypertension. Am J Hypertens (1993) 0.77
Use of calcium antagonists in patients with ischemic heart disease and systemic hypertension. Am J Cardiol (1997) 0.77
The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology (2011) 2.06
Use of X-linked markers for forensic purposes. Int J Legal Med (2003) 1.91
Structural basis of drug binding to L Ca2+ channels. Trends Pharmacol Sci (1998) 1.69
Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels. Neuron (1996) 1.46
16 X-chromosome STR loci frequency data from a German population. Forensic Sci Int (2001) 1.44
Familial hemiplegic migraine mutations change alpha1A Ca2+ channel kinetics. J Biol Chem (1998) 1.44
Pharmacological properties of GABAA receptors containing gamma1 subunits. Mol Pharmacol (2005) 1.32
Endogenous calcium channels in human embryonic kidney (HEK293) cells. Br J Pharmacol (1996) 1.31
Automated fast perfusion of Xenopus oocytes for drug screening. Pflugers Arch (2006) 1.30
State dependent dissociation of HERG channel inhibitors. Br J Pharmacol (2007) 1.27
The action of caffeine on inward barium current through voltage-dependent calcium channels in single rabbit ear artery cells. Pflugers Arch (1990) 1.25
Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity. Neuropharmacology (2007) 1.15
Characterization of the fast sodium current in isolated rat myocardial cells: simulation of the clamped membrane potential. J Physiol (1982) 1.14
Immortalization and transformation of human fibroblasts by regulated expression of polyoma virus T antigens. Oncogene (1990) 1.14
Modulation of slow inactivation in class A Ca2+ channels by beta-subunits. J Physiol (2000) 1.04
Nine L-type amino acid residues confer full 1,4-dihydropyridine sensitivity to the neuronal calcium channel alpha1A subunit. Role of L-type Met1188. J Biol Chem (1997) 1.02
Inactivation determinants in segment IIIS6 of Ca(v)3.1. J Physiol (2001) 1.02
Valerenic acid derivatives as novel subunit-selective GABAA receptor ligands - in vitro and in vivo characterization. Br J Pharmacol (2010) 0.99
Sodium and calcium currents in neuroblastoma x glioma hybrid cells before and after morphological differentiation by dibutyryl cyclic AMP. Gen Physiol Biophys (1985) 0.99
High affinity interaction of mibefradil with voltage-gated calcium and sodium channels. Br J Pharmacol (2000) 0.97
A light stabilizer (Tinuvin 770) that elutes from polypropylene plastic tubes is a potent L-type Ca(2+)-channel blocker. Proc Natl Acad Sci U S A (1993) 0.97
Block of P/Q-type calcium channels by therapeutic concentrations of aminoglycoside antibiotics. Biochemistry (1996) 0.96
Two amino acid residues in the IIIS5 segment of L-type calcium channels differentially contribute to 1,4-dihydropyridine sensitivity. J Biol Chem (1996) 0.95
Molecular mechanism of diltiazem interaction with L-type Ca2+ channels. J Biol Chem (1998) 0.94
Molecular mechanism of calcium channel block by isradipine. Role of a drug-induced inactivated channel conformation. J Biol Chem (2000) 0.92
Air quality measurements from the Fresno Supersite. J Air Waste Manag Assoc (2000) 0.91
Sequence differences between alpha1C and alpha1S Ca2+ channel subunits reveal structural determinants of a guarded and modulated benzothiazepine receptor. J Biol Chem (1999) 0.90
Extra- and intracellular action of quaternary devapamil on muscle L-type Ca(2+)-channels. Br J Pharmacol (1996) 0.90
Trapping and dissociation of propafenone derivatives in HERG channels. Br J Pharmacol (2011) 0.90
Amino acids in segment IVS6 and beta-subunit interaction support distinct conformational changes during Ca(v)2.1 inactivation. J Biol Chem (2001) 0.88
Transfer of L-type calcium channel IVS6 segment increases phenylalkylamine sensitivity of alpha1A. J Biol Chem (1996) 0.88
Stimulation of cell division and fibroblast focus formation by antisense repression of retinoblastoma protein synthesis. Oncogene (1992) 0.88
Voltage clamp method on single cardiac cells from adult rat heart. Experientia (1980) 0.86
Chimeric L-type Ca2+ channels expressed in Xenopus laevis oocytes reveal role of repeats III and IV in activation gating. J Physiol (1995) 0.86
Mechanism of voltage- and use-dependent block of class A Ca2+ channels by mibefradil. Br J Pharmacol (1998) 0.86
Molecular basis of drug interaction with L-type Ca2+ channels. J Bioenerg Biomembr (1998) 0.85
Use- and voltage-dependent depression by ethmozine (moricizine) of the rapid inward sodium current in single rat ventricular muscle cells. J Cardiovasc Pharmacol (1986) 0.85
Improved micro-perfusion chamber for multiple and rapid solution exchange in adherent single cells. Pflugers Arch (1995) 0.84
Estimating the efficiency of benzodiazepines on GABA(A) receptors comprising gamma1 or gamma2 subunits. Br J Pharmacol (2008) 0.84
Sodium current in freshly isolated and in cultured single rat myocardial cells: frequency and voltage-dependent block by mexiletine. J Mol Cell Cardiol (1983) 0.84
Cloning and functional expression of a neuronal calcium channel beta subunit from house fly (Musca domestica). J Biol Chem (1994) 0.84
Short-term temporal variation in PM2.5 mass and chemical composition during the Atlanta Supersite Experiment, 1999. J Air Waste Manag Assoc (2003) 0.83
Evidence that agonist and antagonist enantiomers of the dihydropyridine PN 202-791 act at different sites on the voltage-dependent calcium channel of vascular muscle. Br J Pharmacol (1990) 0.83
Evidence for an external location of the dihydropyridine agonist receptor site on smooth muscle and skeletal muscle calcium channels. Br J Pharmacol (1993) 0.83
On the role of Ca(2+)- and voltage-dependent inactivation in Ca(v)1.2 sensitivity for the phenylalkylamine (-)gallopamil. Circ Res (2001) 0.82
Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats. Eur J Cardiothorac Surg (2004) 0.82
Inactivation determinant in the I-II loop of the Ca2+ channel alpha1-subunit and beta-subunit interaction affect sensitivity for the phenylalkylamine (-)gallopamil. J Physiol (1999) 0.81
A kinetic analysis of the inward calcium current in 108CC15 neuroblastoma x glioma hybrid cells. Gen Physiol Biophys (1985) 0.81
A comparative study of three different biomaterials in the engineering of skeletal muscle using a rat animal model. Biomaterials (2004) 0.81
[Stem cell therapy for urinary incontinence]. Urologe A (2004) 0.81
Mitochondrial DNA in the Central European population. Human identification with the help of the forensic mt-DNA D-loop-base database. Forensic Sci Int (2000) 0.80
Calcium channel block by (-)devapamil is affected by the sequence environment and composition of the phenylalkylamine receptor site. Biophys J (1997) 0.80
X chromosomal and autosomal loss of heterozygosity and microsatellite instability in human cervical carcinoma. Int J Gynecol Cancer (2006) 0.78
Methods for quantification of pore-voltage sensor interaction in Ca(V)1.2. Pflugers Arch (2013) 0.78
A method for estimation of drug affinity constants to the open conformational state of calcium channels. Biophys J (1992) 0.77
[35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties. Mol Pharmacol (1992) 0.77
[Investigations on the endoparasitic fauna of domestic cats in eastern Brandenburg]. Berl Munch Tierarztl Wochenschr (1997) 0.77
On the fate of skeletal myoblasts in a cardiac environment: down-regulation of voltage-gated ion channels. J Physiol (2004) 0.76
[Airway manifestations of relapsing polychondritis: treatment with cyclophosphamide and placement of bronchial stents]. Z Rheumatol (2003) 0.76
TNFa and b microsatellites in Germany. Int J Legal Med (1998) 0.76
[Free fatty acids in the serum in critical diseases: do they play a role in the protein binding of thyroid hormones?]. Klin Wochenschr (1988) 0.75
Comments on the paper entitled "polymorphism of nine X chromosomal STR loci in Koreans" by Jin Young Son et al. (2002) Int J Legal Med 116:317-321. Int J Legal Med (2003) 0.75
Interaction of diltiazem with an intracellularly accessible binding site on Ca(V)1.2. Br J Pharmacol (2011) 0.75
Thyroid hormone binding inhibition in critically ill patients--who is the inhibitor? Exp Clin Endocrinol (1990) 0.75
[Hepatomegaly und elevated transaminases in a 24-year-old with type I diabetes mellitus]. Internist (Berl) (2010) 0.75
Cell-attached patch clamp measurement of macroscopic rapid inward sodium current in cultured heart cell reaggregates. J Mol Cell Cardiol (1987) 0.75
A patch clamp study of the action of ethacyzine on the rapid inward sodium current in single rat heart muscle cells. Eur J Pharmacol (1986) 0.75
Trapidil and other 5-triazolo-(1, 5-alpha)-pyrimidine derivatives as calcium channel blockers in 108CC5 cells. Biomed Biochim Acta (1985) 0.75
Calcium channel block by phenytoin in neuroblastoma x glioma hybrid cells. Biomed Biochim Acta (1985) 0.75
Reactivity of monoclonal anti-K 562 antibodies with cells of leukemia- and lymphoma-patients. Arch Geschwulstforsch (1985) 0.75
Benzothiazepine binding domain of purified L-type calcium channels: direct labeling using a novel fluorescent diltiazem analogue. Biochemistry (1995) 0.75
[Frequency-dependent blockade of sodium channels in isolated rat myocardial cells by the anti-arrhythmia agent ethmozine]. Biull Eksp Biol Med (1986) 0.75
[Calcium current effects in the presence and absence of propranolol on cloned neuroblastoma and glioma hybrid cells]. Biomed Biochim Acta (1988) 0.75
Paraoxonase 1 192 Gln/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetes. Exp Clin Endocrinol Diabetes (2001) 0.75
Production and characterization of monoclonal antibodies against the human leukemic cell line K562. Haematol Blood Transfus (1985) 0.75
Monoclonal antibodies against the human leukemia cell line K 562. Arch Geschwulstforsch (1985) 0.75
Differences of K562 leukemia cell clones in the pattern of monoclonal antibody binding and NK cell susceptibility. Biomed Biochim Acta (1986) 0.75
Tumor necrosis factor-alpha prevents interleukin-1 beta from augmenting capsaicin-induced vasodilatation in the rat skin. Eur J Pharmacol (1995) 0.75
Inhibition of calcium channels in neuroblastoma x glioma hybrid cells by verapamil, D600, diltiazem and nisoldipine. Biomed Biochim Acta (1987) 0.75
Analysis and simulation of wintertime light scattering by the urban aerosol in Dallas-Fort Worth. J Air Waste Manag Assoc (2000) 0.75
Migration of K562 cells and its inhibition by lymphokines. Biomed Biochim Acta (1983) 0.75
Interleukin 1 beta, but not tumor necrosis factor, enhances neurogenic vasodilatation in the rat skin: involvement of nitric oxide. Can J Physiol Pharmacol (1995) 0.75